Get the Stockscreener App
16.30
3.09%
-0.52
Pre-market:
16.94
0.64
+3.93%
Eton Pharmaceuticals Inc stock is traded at $16.30, with a volume of 286.30K.
It is down -3.09% in the last 24 hours and down -11.41% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$16.82
Open:
$16.78
24h Volume:
286.30K
Relative Volume:
1.00
Market Cap:
$437.13M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-62.69
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
-3.44%
1M Performance:
-11.41%
6M Performance:
-16.84%
1Y Performance:
+56.28%
1-Day Range:
$16.24
$17.27
1-Week Range:
$16.24
$17.77
52-Week Range:
$10.20
$23.00
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
16.30 | 451.07M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Is Eton Pharmaceuticals Inc. stock positioned for digital transformationMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Why Eton Pharmaceuticals Inc. stock is favored by top institutions2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Can Eton Pharmaceuticals Inc. stock hit record highs againJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Is Eton Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
[S-8] Eton Pharmaceuticals, Inc. Employee Benefit Plan Registration | ETON SEC FilingForm S-8 - Stock Titan
Is Eton Pharmaceuticals Inc. stock bottoming outPortfolio Gains Summary & Real-Time Market Trend Scan - newser.com
Using RSI to spot recovery in Eton Pharmaceuticals Inc.Dividend Hike & Daily Volume Surge Trade Alerts - newser.com
[8-K/A] Eton Pharmaceuticals, Inc. Amends Material Event Report | ETON SEC FilingForm 8-K/A - Stock Titan
Eton Pharmaceuticals (NASDAQ:ETON) Stock Rating Lowered by Zacks Research - MarketBeat
Will Eton Pharmaceuticals Inc. stock see insider buyingAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - newser.com
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Share Price Matching Investor Opinion - simplywall.st
Institutional Investors in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Lost 12% Last Week but Have Reaped the Benefits of Longer-term Growth - 富途牛牛
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th - The Manila Times
Eton Pharmaceuticals (NASDAQ: ETON) to Attend 16th Craig-Hallum Alpha Select Nov. 18 - Stock Titan
Liquidity Mapping Around (ETON) Price Events - news.stocktradersdaily.com
Eton Pharmaceuticals (NASDAQ:ETON) Announces Quarterly Earnings Results - MarketBeat
Eton Pharma (ETON) Q3 2025 Earnings Transcript - AOL.com
Can Eton Pharmaceuticals Inc. hit a new high this monthTrend Reversal & Verified Trade Idea Suggestions - newser.com
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Eton Pharmaceuticals Delivers Rapid Growth And Analyst Approval - Finimize
Anchor Capital Advisors LLC Has $1.25 Million Stock Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Earnings call transcript: Eton Pharmaceuticals Q3 2025 misses EPS forecasts By Investing.com - Investing.com Australia
Eton Pharmaceuticals Reports Strong Q3 2025 Growth - TipRanks
Earnings call transcript: Eton Pharmaceuticals Q3 2025 misses EPS forecasts - Investing.com
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):